UBS Maintains Neutral on Exelixis, Raises Price Target to $52

Benzinga Newsdesk www.benzinga.com Positive 77.5%

Neg 0% Neu 0% Pos 77.5%

UBS analyst Ashwani Verma maintains Exelixis (NASDAQ:EXEL) with a Neutral and raises the price target from $43 to $52.

Comments

No comments yet. Be the first!